Therefore, it is suggested that IL-13Rα2 might be important in the metastatic potential of cancer cells, and advanced cancer with higher expression of IL-13Rα2 might benefit from new therapies based on blocking the IL-13Rα2 pathway. The gene discussed is IL13RA2; the disease is cancer.